Featured Research

from universities, journals, and other organizations

Nationwide study: One in four women show ambivalence toward pregnancy

Date:
May 12, 2010
Source:
University of Nebraska-Lincoln
Summary:
For years, a widely held assumption was that women of childbearing age fell neatly into two camps: those trying to have children, and those not trying to have children. A new nationwide study suggests, however, that nearly a fourth of women consider themselves "OK either way" about getting pregnant -- a wide swath of ambivalence that surprised researchers, and that could reshape how doctors approach many aspects of women's health care. The results surprised researchers, and could reshape how doctors approach women's health care.

Julia McQuillan in her research lab.
Credit: Image courtesy of University of Nebraska-Lincoln

For years, a widely held assumption was that women of childbearing age fell neatly into two camps: those trying to have children, and those not trying to have children.

A new nationwide study suggests, however, that nearly a fourth of women consider themselves "OK either way" about getting pregnant -- a wide swath of ambivalence that surprised researchers, and that could reshape how doctors approach many aspects of women's health care.

In a study of nearly 4,000 women ages 25 to 45 who are sexually active, about 71 percent said they were not trying to get pregnant, while 6 percent said they were. But nearly one in four, 23 percent, told researchers they were "OK either way" -- they were neither trying to conceive, nor trying to prevent a pregnancy.

Among women who had no children, 60 percent said they were trying to not get pregnant, 14 percent were trying to get pregnant and 26 percent responded that they were "OK either way."

"This finding dramatically challenges the idea that women are always trying, one way or another, to either get pregnant or not get pregnant," said Julia McQuillan, professor of sociology at the University of Nebraska-Lincoln and the study's lead author. "It also shows that women who are OK either way should be assessed separately from women who are intentional about pregnancy."

The study also gave more accurate measures of women's pregnancy intentions, which are important for estimating unmet need for contraception, building more effective family planning programs, promoting infant health and helping maternal and infant well-being.

"If health-care providers only ask women if they are currently trying to get pregnant and women say no, then the assumption is that they are trying not to get pregnant," McQuillan said. "Clearly, many women are less intentional about pregnancy. Yet this group should be treated as if they will likely conceive and should therefore get recommendations such as ensuring adequate folic acid intake and limiting alcohol intake."

In addition, the study examined the attitudes and social pressures regarding pregnancy of the respondents, as well as their socioeconomic status.

Among the findings:

  • Women who said they were OK either way reported the highest number when asked what the ideal number of children would be -- 3.17 on average. They also tended to be slightly more religious than women who were either trying to get pregnant or not trying to get pregnant.
  • Seventy-three percent of women who said they were OK either way said they would like a baby, compared with 34 percent of women who were not trying to get pregnant, and 95 percent of women who said they were trying to get pregnant.
  • Those who were trying to get pregnant were more likely to report that having a child -- or another child -- was very important to their partner compared with women in the other two groups. Among women who had not yet had children and who said they were trying, 40 percent said it was important to their partner.
  • Half of all women in the survey said their career was very important to them, while 45 percent said the same about having an adequate amount of leisure time. All three groups -- women who were trying, women who weren't trying, and women who were OK either way -- reported similar attitudes about work and leisure.

The study, which is forthcoming in Maternal and Child Health Journal, was authored by UNL's McQuillan along with Arthur L. Greil of Alfred University and Karina Shreffler of Oklahoma State University.


Story Source:

The above story is based on materials provided by University of Nebraska-Lincoln. The original article was written by Steve Smith. Note: Materials may be edited for content and length.


Journal Reference:

  1. Julia McQuillan, Arthur L. Greil, Karina M. Shreffler. Pregnancy Intentions Among Women Who Do Not Try: Focusing on Women Who Are Okay Either Way. Maternal and Child Health Journal, 2010; DOI: 10.1007/s10995-010-0604-9

Cite This Page:

University of Nebraska-Lincoln. "Nationwide study: One in four women show ambivalence toward pregnancy." ScienceDaily. ScienceDaily, 12 May 2010. <www.sciencedaily.com/releases/2010/05/100506102938.htm>.
University of Nebraska-Lincoln. (2010, May 12). Nationwide study: One in four women show ambivalence toward pregnancy. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/05/100506102938.htm
University of Nebraska-Lincoln. "Nationwide study: One in four women show ambivalence toward pregnancy." ScienceDaily. www.sciencedaily.com/releases/2010/05/100506102938.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins